Free Trial
→ Elon’s BIGGEST warning yet? (From Brownstone Research) (Ad) Buy OXBDF Stock  Free OXBDF Stock Alerts

Oxford Biomedica (OXBDF) Short Interest Ratio & Short Volume

Oxford Biomedica logo
$4.66 0.00 (0.00%)
As of 06/12/2025
Compare

Oxford Biomedica Short Interest Data

Oxford Biomedica (OXBDF) has a short interest of 314,600 shares, representing 0.30% of the float (the number of shares available for trading by the public). This marks a 2.58% increase in short interest from the previous month. The short interest ratio (days to cover) is 185.1, indicating that it would take 185.1 days of the average trading volume of 12,757 shares to cover all short positions.

Current Short Interest
314,600 shares
Previous Short Interest
306,700 shares
Change Vs. Previous Month
+2.58%
Dollar Volume Sold Short
$1.47 million
Short Interest Ratio
185.1 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
105,962,000 shares
Short Percent of Float
0.30%
Today's Trading Volume
0 shares
Average Trading Volume
12,757 shares
Today's Volume Vs. Average
0%
Short Selling Oxford Biomedica?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Oxford Biomedica and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

OXBDF Short Interest Over Time

OXBDF Days to Cover Over Time

OXBDF Percentage of Float Shorted Over Time

Oxford Biomedica Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/2025314,600 shares $1.47 million +2.6%0.3%185.1 $4.66
5/15/2025306,700 shares $1.20 million +1.4%0.3%766.8 $3.93
4/30/2025302,400 shares $1.19 million +0.8%N/A10 $3.95
4/15/2025299,900 shares $944.69 thousand +21.4%0.3%107.1 $3.15
3/31/2025247,000 shares $958.36 thousand +83.5%0.2%1235 $3.88
3/15/2025134,600 shares $475.14 thousand +71.9%0.1%67.3 $3.53
2/28/202578,300 shares $325.73 thousand +131.0%0.1%17 $4.16
2/15/202533,900 shares $169.50 thousand +74.7%0.0%2.3 $5.00
1/31/202519,400 shares $107.86 thousand +385.0%N/A194 $5.56
1/15/20254,000 shares $19.80 thousand +166.7%N/A4.4 $4.95
12/31/20241,500 shares $8.09 thousand +87.5%N/A7.5 $5.40
12/15/2024800 shares $4.28 thousand +300.0%N/A8 $5.35
11/30/2024200 shares $1.04 thousand +100.0%N/A1 $5.20
11/15/2024100 shares $541.05 -96.2%N/A0 $5.41
10/31/20242,600 shares $14.69 thousand +2,500.0%N/A3.7 $5.65
10/15/2024100 shares $510.00 No ChangeN/A1 $5.10
9/30/2024100 shares $501.90 -66.7%N/A0 $5.02
9/15/2024300 shares $1.26 thousand -88.9%N/A0 $4.21
8/31/20242,700 shares $11.96 thousand No ChangeN/A0.1 $4.43
7/31/2024100 shares $473.00 No ChangeN/A0 $4.73
6/15/2024100 shares $410.00 No ChangeN/A0.1 $4.10
5/31/2024100 shares $440.06 No ChangeN/A1 $4.40
5/15/2024100 shares $386.00 -80.0%N/A1 $3.86
4/30/2024500 shares $1.46 thousand -37.5%N/A0.7 $2.91
4/15/2024800 shares $2.09 thousand -42.9%N/A4 $2.62
3/31/20241,400 shares $3.40 thousand +133.3%N/A2 $2.43
3/15/2024600 shares $1.46 thousand +100.0%N/A1 $2.44
2/29/2024300 shares $654.00 +200.0%N/A0.1 $2.18
2/15/2024100 shares $230.00 -99.6%N/A0 $2.30
1/15/2024300 shares $807.00 No ChangeN/A0 $2.69
12/31/2023300 shares $807.00 +50.0%N/A0 $2.69
12/15/2023200 shares $526.00 -99.7%N/A0 $2.63
11/30/202358,700 shares $131.49 thousand -2.0%N/A195.7 $2.24
11/15/202359,900 shares $157.54 thousand -2.1%N/A2 $2.63
10/31/202361,200 shares $169.52 thousand -2.1%N/A1.3 $2.77
10/15/202362,500 shares $229.69 thousand -21.4%N/A31.3 $3.68
9/30/202379,500 shares $283.42 thousand +0.3%N/A5 $3.57
9/15/202379,300 shares $255.35 thousand -27.2%N/A4.7 $3.22
8/31/2023108,900 shares $459.56 thousand +38.0%N/A6.8 $4.22
8/15/202378,900 shares $336.90 thousand No ChangeN/A5.5 $4.27
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
7/31/202378,900 shares $457.62 thousand +10.0%N/A131.5 $5.80
7/15/202371,700 shares $402.60 thousand +21.9%N/A717 $5.62
6/30/202358,800 shares $316.34 thousand +17.1%N/A5.4 $5.38
6/15/202350,200 shares $290.66 thousand No ChangeN/A5.5 $5.79
5/31/202350,200 shares $274.34 thousand No ChangeN/A50.2 $5.47
5/15/202350,200 shares $277.36 thousand No ChangeN/A502 $5.53
4/30/202350,200 shares $277.36 thousand -0.6%N/A502 $5.53
4/15/202350,500 shares $270.18 thousand +0.6%N/A1.4 $5.35
3/31/202350,200 shares $262.80 thousand -0.6%N/A5.6 $5.24
3/15/202350,500 shares $309.82 thousand +0.4%N/A505 $6.14
2/28/202350,300 shares $314.38 thousand No ChangeN/A251.5 $6.25
2/15/202350,300 shares $302.81 thousand -0.2%N/A22.9 $6.02
1/31/202350,400 shares $257.04 thousand -1.6%N/A18 $5.10
1/15/202351,200 shares $291.84 thousand +34.7%N/A9.8 $5.70
12/30/202238,000 shares $198.36 thousand +62.4%N/A6 $5.22
12/15/202223,400 shares $108.81 thousand +87.2%N/A33.4 $4.65
11/30/202212,500 shares $53 thousand -3.1%N/A62.5 $4.24
11/15/202212,900 shares $48.25 thousand +9.3%N/A1.6 $3.74
10/31/202211,800 shares $43.42 thousand -0.8%N/A0.7 $3.68
10/15/202211,900 shares $42.72 thousand -0.8%N/A0.4 $3.59
9/30/202212,000 shares $46.92 thousand -0.8%N/A0.6 $3.91
9/15/202212,100 shares $63.04 thousand +3.4%N/A5 $5.21
8/31/202211,700 shares $64.35 thousand +148.9%N/A39 $5.50
8/15/20224,700 shares $29.45 thousand -17.5%N/A1.3 $6.27
7/31/20225,700 shares $32.83 thousand +23.9%N/A57 $5.76
7/15/20224,600 shares $24.89 thousand +4.6%N/A7.7 $5.41
6/30/20224,400 shares $24.07 thousand -8.3%N/A22 $5.47
6/15/20224,800 shares $25.06 thousand -37.7%N/A16 $5.22
5/31/20227,700 shares $47.28 thousand +67.4%N/A8.6 $6.14
5/15/20224,600 shares $27.42 thousand No ChangeN/A1.8 $5.96
4/30/20224,600 shares $31.43 thousand No ChangeN/A0.5 $6.83
4/15/20224,600 shares $39.10 thousand -66.4%N/A2 $8.50
3/31/202213,700 shares $120.56 thousand +73.4%N/A0.8 $8.80
3/15/20227,900 shares $66.32 thousand +33.9%N/A1.3 $8.40
2/28/20225,900 shares $57.35 thousand No ChangeN/A0.6 $9.72
2/15/20225,900 shares $61.66 thousand +22.9%N/A0.8 $10.45
1/31/20224,800 shares $51.98 thousand No ChangeN/A2.1 $10.83
12/31/2021100 shares $1.67 thousand No ChangeN/A0.2 $16.69
11/30/2021100 shares $1.80 thousand -50.0%N/A0.1 $18.00
11/15/2021200 shares $4.02 thousand -75.0%N/A0.2 $20.11
10/29/2021800 shares $16.30 thousand +14.3%N/A0.9 $20.38
10/15/2021700 shares $14.35 thousand -12.5%N/A0.5 $20.50
9/30/2021800 shares $16.16 thousand +700.0%N/A0.5 $20.20
9/15/2021100 shares $2.03 thousand -50.0%N/A0 $20.33
8/31/2021200 shares $4.13 thousand +100.0%N/A0.1 $20.63
8/13/2021100 shares $1.91 thousand -90.0%N/A0 $19.05
7/30/20211,000 shares $18.73 thousand -16.7%N/A0.4 $18.73
7/15/20211,200 shares $22.11 thousand -81.0%N/A0.6 $18.43
6/30/20216,300 shares $112.77 thousand +12.5%N/A4.5 $17.90
6/15/20215,600 shares $105.28 thousand +19.2%N/A2.8 $18.80
Your Bank Account Is No Longer Safe (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
5/28/20214,700 shares $76.54 thousand -7.8%N/A7.8 $16.29
5/14/20215,100 shares $72.11 thousand No ChangeN/A2.2 $14.14
4/30/20215,100 shares $75.56 thousand +30.8%N/A1.7 $14.82
4/15/20213,900 shares $55.42 thousand No ChangeN/A0.7 $14.21
3/31/20213,900 shares $50.91 thousand -13.3%N/A3.9 $13.06
3/15/20214,500 shares $63.90 thousand +9.8%N/A3.2 $14.20
2/26/20214,100 shares $57.40 thousand -2.4%N/A3.4 $14.00
2/12/20214,200 shares $60.06 thousand -17.7%N/A1 $14.30
1/29/20215,100 shares $68.39 thousand -13.6%N/A2.3 $13.41
1/15/20217,100 shares $89.89 thousand -26.0%N/A1.4 $12.66
12/31/20209,600 shares $132.96 thousand +35.2%N/A2 $13.85
12/15/20207,100 shares $82.93 thousand -26.0%N/A1.4 $11.68
11/30/20209,600 shares $110.88 thousand +23.1%N/A1.7 $11.55
11/15/20207,800 shares $88.73 thousand -2.5%N/A2.6 $11.38
10/30/20208,000 shares $83.60 thousand -14.9%N/A2.4 $10.45
10/15/20209,400 shares $99.17 thousand -4.1%N/A6.7 $10.55
9/30/20209,800 shares $104.42 thousand -4.9%N/A1.8 $10.66
9/15/202010,300 shares $115.88 thousand -12.7%N/A0.6 $11.25
8/31/202011,800 shares $132.28 thousand -9.9%N/A1.3 $11.21
8/14/202013,100 shares $142.27 thousand +44.0%N/A0.8 $10.86
7/31/20209,100 shares $97.60 thousand +111.6%N/A0.2 $10.73
7/15/20204,300 shares $40.31 thousand -32.8%N/A0.5 $9.38
6/30/20206,400 shares $56.51 thousand -23.8%N/A1 $8.83
6/15/20208,400 shares $84 thousand +250.0%N/A0.8 $10.00

OXBDF Short Interest - Frequently Asked Questions

What is Oxford Biomedica's current short interest?

Short interest is the volume of Oxford Biomedica shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 314,600 shares of OXBDF short. 0.30% of Oxford Biomedica's shares are currently sold short. Learn More on Oxford Biomedica's current short interest.

What is a good short interest ratio for Oxford Biomedica?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OXBDF shares currently have a short interest ratio of 185.0. Learn More on Oxford Biomedica's short interest ratio.

What is a good short interest percentage for Oxford Biomedica?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of Oxford Biomedica's floating shares are currently sold short.

Is Oxford Biomedica's short interest increasing or decreasing?

Oxford Biomedica saw a increase in short interest in May. As of May 31st, there was short interest totaling 314,600 shares, an increase of 2.6% from the previous total of 306,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Oxford Biomedica's short interest compare to its competitors?

0.30% of Oxford Biomedica's shares are currently sold short. Here is how the short interest of companies in the industry of "private households" compare to Oxford Biomedica: DeNA Co., Ltd. (0.71%), Alps Alpine Co., Ltd. (0.00%), Shangri-La Asia Limited (0.00%), Pharma Mar, S.A. (0.05%), Safestore Holdings Plc (0.00%), Hino Motors, Ltd. (0.00%), Casio Computer Co.,Ltd. (0.00%), SSP Group plc (0.00%), Ero Copper Corp. (4.34%), Paladin Energy Ltd (3.81%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short Oxford Biomedica stock?

Short selling OXBDF is an investing strategy that aims to generate trading profit from Oxford Biomedica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Oxford Biomedica?

A short squeeze for Oxford Biomedica occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OXBDF, which in turn drives the price of the stock up even further.

How often is Oxford Biomedica's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OXBDF, twice per month. The most recent reporting period available is May, 31 2025.



Related Companies
Short Interest Tools

This page (OTCMKTS:OXBDF) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
Why July 22nd Could Mean Big Changes for Social Security
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...
Altimetry | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Banks aren’t ready for this altcoin—are you?
Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...
Crypto 101 Media | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored